Dashboard
Manage Tickers

ARVNARVINAS, INC.

Nasdaq arvinas.com


$ 25.10 $ -0.18 (-0.72 %)    

Thursday, 05-Sep-2024 15:17:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 24.95
$ 25.05
$ 25.24 x 100
-- x --
$ 24.87 - $ 25.56
$ 13.57 - $ 53.08
402,393
na
1.71B
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-04-2020 06-30-2020 10-Q
18 04-28-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-05-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-26-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-arvinas-maintains-87-price-target
HC Wainwright & Co. Reiterates Buy on Arvi...
08/01/2024 10:39:55

HC Wainwright & Co. analyst Andrew Fein reiterates Arvinas (NASDAQ:ARVN) with a Buy and maintains $87 price target.

wedbush-reiterates-outperform-on-arvinas-maintains-57-price-target
Wedbush Reiterates Outperform on Arvinas, ...
07/31/2024 16:02:42

Wedbush analyst Robert Driscoll reiterates Arvinas (NASDAQ:ARVN) with a Outperform and maintains $57 price target.

cantor-fitzgerald-reiterates-overweight-on-arvinas
Cantor Fitzgerald Reiterates Overweight on...
07/31/2024 15:42:27

Cantor Fitzgerald analyst Li Watsek reiterates Arvinas (NASDAQ:ARVN) with a Overweight.

barclays-maintains-overweight-on-arvinas-lowers-price-target-to-48
Barclays Maintains Overweight on Arvinas, ...
07/31/2024 14:19:58

Barclays analyst Peter Lawson maintains Arvinas (NASDAQ:ARVN) with a Overweight and lowers the price target from $60 to $48.

the-latest-analyst-ratings-for-arvinas
The Latest Analyst Ratings For Arvinas
07/31/2024 14:00:45

oppenheimer-maintains-outperform-on-arvinas-lowers-price-target-to-50
Oppenheimer Maintains Outperform on Arvina...
07/31/2024 12:44:47

Oppenheimer analyst Matthew Biegler maintains Arvinas (NASDAQ:ARVN) with a Outperform and lowers the price target from $70 t...

arvinas-says-its-cash-cash-equivalents-restricted-cash-and-marketable-securities-of-123b-as-of-june-30-2024-is-sufficient-to-fund-planned-operating-expenses-and-capital-expenditure-requirements-into-2027
Arvinas Says Its Cash, Cash Equivalents, R...
07/30/2024 11:20:39

arvinas-q2-2024-gaap-eps-049-beats-083-estimate-sales-76500m-beat-55272m-estimate
Arvinas Q2 2024 GAAP EPS $(0.49) Beats $(0...
07/30/2024 11:19:32

why-charles-schwab-shares-are-trading-lower-by-over-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Charles Schwab Shares Are Trading Lowe...
07/16/2024 17:06:26

unitedhealth-posts-better-than-expected-earnings-joins-angiodynamics-bank-of-america--and-other-big-stocks-moving-higher-on-tuesday
UnitedHealth Posts Better-Than-Expected Ea...
07/16/2024 15:09:23

arvinas-appoints-andrew-saik-to-the-role-of-cfo-and-treasurer
Arvinas Appoints Andrew Saik To The Role O...
06/24/2024 20:38:12

arvinas-says-it-presented-new-preclinical-data-from-its-investigational-bcl6-protac-degrader-arv-393-company-also-disclosed-new-preclinical-data-from-protac-lrrk2-degrader-program
Arvinas Says It Presented New Preclinical ...
06/21/2024 11:16:57

Data presented at EHA showed anti-tumor activity for the company's investigational PROTAC BCL6 degrader, ARV-393, in precli...

analyst-ratings-for-arvinas
Analyst Ratings For Arvinas
05/17/2024 16:01:04

hc-wainwright--co-reiterates-buy-on-arvinas-maintains-87-price-target
HC Wainwright & Co. Reiterates Buy on Arvi...
05/17/2024 14:38:46

HC Wainwright & Co. analyst Andrew Fein reiterates Arvinas (NASDAQ:ARVN) with a Buy and maintains $87 price target.

walmart-posts-upbeat-earnings-joins-canada-goose-lightspeed-commerce-and-other-big-stocks-moving-higher-on-thursday
Walmart Posts Upbeat Earnings, Joins Canad...
05/16/2024 14:24:53

Core News & Articles
Arvinas And Pfizer Report Updated Clinical...
05/16/2024 10:06:15

After six months of additional follow-up, these data are consistent with data presented at the San Antonio Breast Cancer Sympos...

nextracker-posts-upbeat-earnings-joins-mondaycom-nu-holdings-and-other-big-stocks-moving-higher-on-wednesday
NEXTracker Posts Upbeat Earnings, Joins mo...
05/15/2024 14:21:59

wells-fargo-maintains-overweight-on-arvinas-lowers-price-target-to-60
Wells Fargo Maintains Overweight on Arvina...
05/09/2024 15:57:35

Wells Fargo analyst Derek Archila maintains Arvinas (NASDAQ:ARVN) with a Overweight and lowers the price target from $63 to ...

wedbush-reiterates-outperform-on-arvinas-maintains-57-price-target
Wedbush Reiterates Outperform on Arvinas, ...
05/08/2024 14:16:30

Wedbush analyst Robert Driscoll reiterates Arvinas (NASDAQ:ARVN) with a Outperform and maintains $57 price target.

stifel-maintains-buy-on-arvinas-lowers-price-target-to-68
Stifel Maintains Buy on Arvinas, Lowers Pr...
05/08/2024 13:09:44

Stifel analyst Bradley Canino maintains Arvinas (NASDAQ:ARVN) with a Buy and lowers the price target from $72 to $68.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION